logo
Plus   Neg
Share
Email

Aligos Therapeutics Prices IPO Of 10 Mln Shares At $15/Shr, Mid Of Expected Range

Aligos Therapeutics, Inc. (ALGS) announced the pricing of initial public offering of 10 million common shares at $15.00 per share, the mid of the expected range of between $14.00 and $16.00 per share. The offering is expected to close on October 20, 2020.

In addition, Aligos has granted the underwriters a 30-day option to buy additional 1.5 million common shares at the initial public offering price.

The company expects offering gross proceeds, before expenses, to be about $150.0 million, excluding any exercise of the underwriters' option to purchase additional shares.

Aligos' common stock is expected to begin trading on the Nasdaq Global Select Market on October 16, 2020, under the ticker symbol "ALGS".

J.P. Morgan, Jefferies and Piper Sandler are acting as the joint book-running managers for the offering. Cantor is acting as a lead manager for the offering.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration (FDA) has gone ahead with the approval of antiviral drug remdesivir as first treatment for COVID-19, notwithstanding last week's findings by the World Health Organization (WHO) that the drug is not effective for COVID-19 treatment. Thursday, Gilead Sciences announced that the FDA approved remdesivir, sold under the brand name Veklury. Integrated payments firm American Express Co. (AXP) reported Friday that net income for the third quarter declined to $1.1 billion or $1.30 per share from $1.8 billion or $2.08 per share in the prior-year quarter. Consolidated total revenues, net of interest expense, also decreased 20 percent to $8.8... The Federal Trade Commission or FTC has launched a new fraud reporting platform, using which, consumers can easily report fraud and all other consumer issues directly to the regulator. In a statement, the FTC said its new website, ReportFraud.ftc.gov, will provide a streamlined and user-friendly way to submit reports about scams, frauds, and bad business practices.
Follow RTT